1.河南中医药大学康复医学院,河南 郑州 450046
2.河南省中医院康复科//河南中医药大学第二附属医院康复科,河南 郑州 450002
渠燕飞,第一作者,研究方向:神经系统疾病引起功能障碍的中医康复,E-mail:2263383612@qq.com
李彦杰,通信作者,主任医师,研究方向:神经系统疾病引起功能障碍的中医康复,E-mail:yanjieli2008@126.com
收稿:2025-11-20,
修回:2025-12-11,
录用:2026-02-14,
纸质出版:2026-03-20
移动端阅览
渠燕飞,李彦杰.中药调控PI3K/Akt信号通路治疗帕金森病的机制研究进展[J].中山大学学报(医学科学版),2026,47(02):203-215.
QU Yanfei,LI Yanjie.Advances of the Mechanisms Underlying Traditional Chinese Medicine Targeting the PI3K/Akt Pathway against Parkinson's Disease[J].Journal of Sun Yat-sen University(Medical Sciences),2026,47(02):203-215.
渠燕飞,李彦杰.中药调控PI3K/Akt信号通路治疗帕金森病的机制研究进展[J].中山大学学报(医学科学版),2026,47(02):203-215. DOI: 10.11714/jsysu.med.YX20250175.
QU Yanfei,LI Yanjie.Advances of the Mechanisms Underlying Traditional Chinese Medicine Targeting the PI3K/Akt Pathway against Parkinson's Disease[J].Journal of Sun Yat-sen University(Medical Sciences),2026,47(02):203-215. DOI: 10.11714/jsysu.med.YX20250175.
帕金森病(PD)是一种以中脑黑质多巴胺能神经元丢失为特征的神经退行性疾病,现有治疗手段难以逆转其神经变性进程,因此迫切需要神经保护治疗。磷脂酰肌醇3-激酶/蛋白激酶B(PI3K/Akt)信号通路作为调控细胞存活的关键通路,已成为PD干预的重要靶点。近年来,中药以其多靶点、整体调节的特色,在基于PI3K/Akt通路的PD神经保护研究中展现出潜力。然而,该领域研究目前多停留于临床前阶段,缺乏将患者临床终点(如UPDRS评分)与通路生物标志物(如p-Akt水平)相关联的高质量临床证据,制约其临床转化。因此,本文对中药通过调控PI3K/Akt通路防治PD的研究进展进行综述,并展望未来“临床表型-通路活性-中药干预”整合研究的方向,旨在为相关基础研究与临床转化提供参考。
Parkinson’s disease (PD) is a neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) of the midbrain. Current therapeutic strategies are unable to reverse the neurodegenerative process, highlighting an urgent need for neuroprotective interventions. The phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt) signaling pathway, as a key pathway regulating cell survival, has emerged as an important target for PD intervention. In recent years, traditional Chinese medicine (TCM), with its distinctive properties of multi-targeted action and holistic regulation, has demonstrated considerable potential in PD neuroprotection research based on the PI3K/Akt pathway. However, most studies in this field are currently limited to the preclinical stage, and there is a lack of high-quality clinical evidence that correlates patients’ clinical endpoints [e.g., Unified Parkinson’s Disease Rating Scale (UPDRS) scores] with pathway-related biomarkers [e.g., phosphorylated Akt (p-Akt) levels], which hinders its clinical translation. Therefore, this paper reviews the research progress of TCM in the prevention and treatment of PD by regulating the PI3K/Akt pathway, and prospects the future direction of integrated research on “clinical phenotype-pathway activity-TCM intervention”, aiming to provide references for relevant basic research and clinical translation.
Uwishema O , Onyeaka H , Badri R , et al . The understanding of Parkinson's disease through genetics and new therapies [J]. Brain Behav , 2022 , 12 ( 5 ): e2577 .
Armstrong MJ , Okun MS . Diagnosis and treatment of Parkinson disease: a review [J]. Jama , 2020 , 323 ( 6 ): 548 - 560 .
Chu Y , Hirst WD , Federoff HJ , et al . Nigrostriatal tau pathology in Parkinsonism and Parkinson's disease [J]. Brain , 2024 , 147 ( 2 ): 444 - 457 .
邱新晖 , 邱涛 , 刘美辰 , 等 . 神经退行性疾病的小脑症状与影像学特征 [J]. 中国神经精神疾病杂志 , 2024 , 50 ( 9 ): 570 - 576 .
Qiu XH , Qiu T , Liu MC , et al . Cerebellar symptoms and imaging features in neurodegenerative diseases [J]. Chin J Nerv Ment Dis , 2024 , 50 ( 9 ): 570 - 576 .
Jankovic J , Tan EK . Parkinson's disease: etiopathogenesis and treatment [J]. J Neurol Neurosurg Psychiatry , 2020 , 91 ( 8 ): 795 - 808 .
Jia Y , Zhang Y , Tai X , et al . Research progress on natural products in regulating the gut microbiota in Parkinson's disease [J]. Front Pharmacol , 2025 , 16 : 1667694 .
Yang K , Zeng L , Zeng J , et al . Research progress in the molecular mechanism of ferroptosis in Parkinson's disease and regulation by natural plant products [J]. Ageing Res Rev , 2023 , 91 : 102063 .
Long HZ , Cheng Y , Zhou ZW , et al . PI3K/AKT signal pathway: a target of natural products in the prevention and treatment of alzheimer's disease and Parkinson's disease [J]. Front Pharmacol , 2021 , 12 : 648636 .
Goyal A , Agrawal A , Verma A , et al . The PI3K-AKT pathway: a plausible therapeutic target in Parkinson's disease [J]. Exp Mol Pathol , 2023 , 129 : 104846 .
Wright B , King S , Suphioglu C . The importance of phosphoinositide 3-kinase in neuroinflammation [J]. Int J Mol Sci , 2024 , 25 ( 21 ): 11638 .
Huenchuguala S , Segura-aguilar J . A potential role of natural bioactive compounds found in food in the prevention of idiopathic Parkinson's disease [J]. Nutrients , 2025 , 17 ( 21 ): 3376 .
尚小龙 , 王玉 , 徐陈陈 , 等 . 中医药防治帕金森病的机制研究进展 [J]. 中国实验方剂学杂志 , 2023 , 29 ( 17 ): 248 - 259 .
Shang XL , Wang Y , Xu CC , et al . Mechanism of traditional chinese medicine in prevention and treatment of Parkinson's disease:a review [J]. Chin J Exp Tradit Med Formul , 2023 , 29 ( 17 ): 248 - 259 .
Yin R , Xue J , Tan Y , et al . The positive role and mechanism of herbal medicine in Parkinson's disease [J]. Oxid Med Cell Longev , 2021 , 2021 : 9923331 .
Jin X , Dong W , Chang K , et al . Research on the signaling pathways related to the intervention of traditional chinese medicine in Parkinson's disease:a literature review [J]. J Ethnopharmacol , 2024 , 326 : 117850 .
Tian LY , Smit DJ , Jucker M . The role of PI3K/AKT/mTOR signaling in hepatocellular carcinoma metabolism [J]. Int J Mol Sci , 2023 , 24 ( 3 ): 2652 .
Wang J , An Z , Wu Z , et al . Spatial organization of PI3K-PI(3,4,5)P(3)-AKT signaling by focal adhesions [J]. Mol Cell , 2024 , 84 ( 22 ): 4401 - 18.e9 .
Manning BD , Toker A . AKT/PKB signaling: navigating the network [J]. Cell , 2017 , 169 ( 3 ): 381 - 405 .
Shang M , Ni L , Shan X , et al . MTHFD2 reprograms macrophage polarization by inhibiting PTEN [J]. Cell Rep , 2023 , 42 ( 5 ): 112481 .
Lee YR , Chen M , Pandolfi PP . The functions and regulation of the PTEN tumour suppressor: new modes and prospects [J]. Nat Rev Mol Cell Biol , 2018 , 19 ( 9 ): 547 - 562 .
Khasarah G , Nabilsi DA , Madani O , et al . PTEN defects in cancer, from gene to protein molecular causes and therapeutic targets [J]. Discov Oncol , 2025 , 16 ( 1 ): 1649 .
Fakhri S , Iranpanah A , Gravandi MM , et al . Natural products attenuate PI3K/AKT/MTOR signaling pathway: a promising strategy in regulating neurodegeneration [J]. Phytomedicine , 2021 , 91 : 153664 .
Alrouji M , Al-kuraishy HM , Al-gareeb A I , et al . NF-κB/NLRP3 inflammasome axis and risk of Parkinson's disease in type 2 diabetes mellitus: a narrative review and new perspective [J]. J Cell Mol Med , 2023 , 27 ( 13 ): 1775 - 1789 .
Liu K , An J , Zhang J , et al . Network pharmacology combined with experimental validation show that apigenin as the active ingredient of campsis grandiflora flower against Parkinson's disease by inhibiting the PI3K/AKT/NF-κB pathway [J]. PLoS One , 2024 , 19 ( 10 ): e0311824 .
Liu T , Kong X , Qlao J , et al . Decoding Parkinson's disease: the interplay of cell death pathways, oxidative stress, and therapeutic innovations [J]. Redox Biol , 2025 , 85 : 103787 .
Alruwaili R , Al-kuraishy HM , Al-Gareeb A I , et al . Targeting of the PI3K/AKT/GSK3β pathway in parkinson's disease: a therapeutic blueprint [J]. Mol Neurobiol , 2025 , 62 ( 11 ): 15108 - 15131 .
Soni D , Kumar P . GSK-3β-mediated regulation of Nrf2/HO-1 signaling as a new therapeutic approach in the treatment of movement disorders [J]. Pharmacol Rep , 2022 , 74 ( 4 ): 557 - 569 .
Wang Y , Zhang X , Zhang W , et al . Melatonin protects dopaminergic neurons in paraquat-induced Parkinson in rats through PI3K/AKT/Nrf2 pathway [J]. Food Chem Toxicol , 2025 , 203 : 115600 .
Yu Q , Zhang R , Li T , et al . Mitochondrial hydrogen peroxide activates PTEN and inactivates Akt leading to autophagy inhibition-dependent cell death in neuronal models of Parkinson's disease [J]. Mol Neurobiol , 2023 , 60 ( 6 ): 3345 - 3364 .
Araujo B , Caridade-silva R , Soares-guedes C , et al . Neuroinflammation and Parkinson's disease-from neurodegeneration to therapeutic opportunities [J]. Cells , 2022 , 11 ( 18 ): 2908 .
Li Y , Xia Y , Yin S , et al . Targeting microglial α-synuclein/TLRs/NF-kappaB/NLRP3 inflammasome axis in Parkinson's disease [J]. Front Immunol , 2021 , 12 : 719807 .
Wang M , Liu M , Ma Z . Cannabinoid type 2 receptor activation inhibits MPP(+)-induced M1 differentiation of microglia through activating PI3K/Akt/Nrf2 signal pathway [J]. Mol Biol Rep , 2023 , 50 ( 5 ): 4423 - 4433 .
Liu S , Yao S , Yang H , et al . Autophagy: regulator of cell death [J]. Cell Death Dis , 2023 , 14 ( 10 ): 648 .
Nechushtai L , Frenkel D , Pinkas-kramarski R . Autophagy in Parkinson's disease [J]. Biomolecules , 2023 , 13 ( 10 ): 1435 .
Heras-sandoval D , Perez-rojas JM , Hernandez-damian J , et al . The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration [J]. Cell Signal , 2014 , 26 ( 12 ): 2694 - 2701 .
Zhao Y , Ma Y , Xiong L , et al . Neuroprotective effect of the herbal pair coptidis rhizoma-cinnamomi cortex against 6-OHDA-induced Parkinson's disease rats through promotion of autophagy via the PI3K/AKT/mTOR pathway [J]. J Ethnopharmacol , 2025 , 355 ( Pt A ): 120582 .
Santos-lobato BL , Vidal AF , Ribeiro-dos-santos  . Regulatory miRNA-mRNA networks in Parkinson's disease [J]. Cells , 2021 , 10 ( 6 ): 1410 .
Wu X , Wen Y , Yuan Y , et al . The AKT-USP15 axis modulates autophagy in MPP(+)-induced Parkinson's disease model of SN4741 cells [J]. Cell Signal , 2025 , 134 : 111879 .
Li Y , Pang J , Wang J , et al . Knockdown of PDCD4 ameliorates neural cell apoptosis and mitochondrial injury through activating the PI3K/AKT/mTOR signal in Parkinson's disease [J]. J Chem Neuroanat , 2023 , 129 : 102239 .
Wang B , Wang L , Qu Y , et al . Chitosan oligosaccharides exert neuroprotective effects via modulating the PI3K/Akt/Bcl-2 pathway in a Parkinsonian model [J]. Food Funct , 2022 , 13 ( 10 ): 5838 - 5853 .
Farid HA , Sayed RH , El-shamarka M E , et al . PI3K/AKT signaling activation by roflumilast ameliorates rotenone-induced Parkinson's disease in rats [J]. Inflammopharmacology , 2024 , 32 ( 2 ): 1421 - 1437 .
Jin T , Zhang Y , Botchway BO A , et al . Curcumin can improve Parkinson's disease via activating BDNF/PI3k/Akt signaling pathways [J]. Food Chem Toxicol , 2022 , 164 : 113091 .
Mesa-infante V , Afonso-oramas D , Salas-hernandez J , et al . Long-term exposure to GDNF induces dephosphorylation of Ret, AKT, and ERK1/2, and is ineffective at protecting midbrain dopaminergic neurons in cellular models of Parkinson's disease [J]. Mol Cell Neurosci , 2022 , 118 : 103684 .
Yao S , Li L , Sun X , et al . FTY720 inhibits MPP(+)-induced microglial activation by affecting NLRP3 inflammasome activation [J]. J Neuroimmune Pharmacol , 2019 , 14 ( 3 ): 478 - 492 .
刘京 , 刘得水 , 荣华 , 等 . 帕金森病中医药研究进展 [J]. 中国老年学杂志 , 2022 , 42 ( 19 ): 4878 - 4881 .
Liu J , Liu DS , Rong H , et al . Research progress of traditional chinese medicine in Parkinson's disease [J]. Chin J Gerontol , 2022 , 42 ( 19 ): 4878 - 4881 .
Jun P , Zhao H , Jung IC , et al . Traditional medicine classification based on the nature and location of disease in Parkinson's disease: a clustering study using pattern identification disassemble presented in clinical studies [J]. J Integr Complement Med , 2024 , 30 ( 2 ): 99 - 106 .
王佳彬 , 沈晓明 , 马云枝 , 等 . 帕金森病中西医研究进展 [J]. 中国实验方剂学杂志 , 2021 , 28 ( 01 ): 241 - 250 .
Wang JB , Shen XM , Ma YZ , et al . Research progress of integrated traditional chinese and western medicine in Parkinson's disease [J]. Chin J Exp Tradit Med Formul , 2021 , 28 ( 1 ): 241 - 250 .
Huang L , Li Q , Wu J , et al . Galangin reduces MPTP-induced dopamine neuron injury via the autophagy dependent-PI3K/AKT pathway [J]. Front Aging Neurosci , 2025 , 17 : 1568002 .
Li Y , Man M , Tian Y , et al . Quercetin protects against neuronal toxicity by activating the PI3K/Akt/GSK-3β pathway in vivo models of MPTP-induced Parkinson's disease [J]. Inflammopharmacology , 2025 , 33 ( 7 ): 4063 - 4076 .
贾冬雪 , 杜静 , 王书华 . 荭草苷对脑缺血再灌注大鼠脑组织线粒体自噬的影响 [J]. 中国老年学杂志 , 2023 , 43 ( 04 ): 925 - 929 .
Jia DX , Du J , Wang SH . Effect of orientin on mitophagy of brain tissue in rats with cerebral ischemia-reperfusion [J]. Chin J Gerontol , 2023 , 43 ( 4 ): 925 - 929 .
Vasudevan Sajini D , Thaggikuppe Krishnamurthy P , Chakkittukandiyil A , et al . Orientin modulates Nrf2-ARE, PI3K/Akt, JNK-ERK1/2, and TLR4/NF-kB pathways to produce neuroprotective benefits in Parkinson's disease [J]. Neurochem Res , 2024 , 49 ( 6 ): 1577 - 1587 .
Yu L , Hu X , Xu R , et al . Piperine promotes PI3K/AKT/mTOR-mediated gut-brain autophagy to degrade α-synuclein in Parkinson's disease rats [J]. J Ethnopharmacol , 2024 , 322 : 117628 .
Bao X , He Y , Huang L , et al . Sinomenine exerts a neuroprotective effect on PD mouse model through inhibiting PI3K/AKT/mTOR pathway to enhance autophagy [J]. Int J Neurosci , 2024 , 134 ( 3 ): 301 - 309 .
Zheng M , Chen M , Wang W , et al . Protection by rhynchophylline against MPTP/MPP(+)-induced neurotoxicity via regulating PI3K/Akt pathway [J]. J Ethnopharmacol , 2021 , 268 : 113568 .
Deng H , Jia Y , Pan D , et al . Berberine alleviates rotenone-induced cytotoxicity by antioxidation and activation of PI3K/Akt signaling pathway in SH-SY5Y cells [J]. Neuroreport , 2020 , 31 ( 1 ): 41 - 47 .
Quan S , Li J , Ding S , et al . Artemether exerts neuroprotective effect in Parkinson's disease through the PI3K/Akt/GSK-3β signaling pathway [J]. Eur J Pharmacol , 2025 , 996 : 177566 .
Guo L , Qu B , Song C , et al . Celastrol attenuates 6-hydroxydopamine-induced neurotoxicity by regulating the miR-146a/PI3K/Akt/mTOR signaling pathways in differentiated rat pheochromocytoma cells [J]. J Affect Disord , 2022 , 316 : 233 - 242 .
He D , Hu G , Zhou A , et al . Echinocystic acid inhibits inflammation and exerts neuroprotective effects in MPTP-induced Parkinson's disease model mice [J]. Front Pharmacol , 2021 , 12 : 787771 .
Shao J , Liu X , Lian M , et al . Citronellol prevents 6-OHDA-induced oxidative stress, mitochondrial dysfunction, and apoptosis in Parkinson disease model of SH-SY5Y cells via modulating ROS-NO, MAPK/ERK, and PI3K/Akt signaling pathways [J]. Neurotox Res , 2022 , 40 ( 6 ): 2221 - 2237 .
Cai B , Wang Q , Zhong L , et al . Integrating network pharmacology, transcriptomics to reveal neuroprotective of curcumin activate PI3K/AKT pathway in Parkinson's disease [J]. Drug Des Devel Ther , 2024 , 18 : 2869 - 2881 .
吴忧 , 梁顺利 , 徐彬 , 等 . 姜黄素通过抑制PI3K/Akt/mTOR通路增强自噬保护帕金森病细胞模型的研究 [J]. 中国现代应用药学 , 2021 , 38 ( 19 ): 2351 - 2358 .
Wu Y , Liang SL , Xu B , et al . Study on curcumin enhances autophagy by inhibiting PI3K/Akt/mTOR pathway to protect cell modelsof Parkinson’s disease [J]. Chin J Mod Appl Pharm , 2021 , 38 ( 19 ): 2351 - 2358 .
Huang N , Huang J , Zhang Y , et al . Resveratrol against 6-OHDA-induced damage of PC12 cells via PI3K/Akt [J]. Transl Neurosci , 2021 , 12 ( 1 ): 138 - 144 .
杨小鸥 , 杨国伟 , 刘志孝 , 等 . 白藜芦醇通过PI3K/Akt/GSK-3β通路对6-OHDA致帕金森病小鼠神经退行性病变改善的作用研究 [J]. 中西医结合心脑血管病杂志 , 2020 , 18 ( 12 ): 1880 - 1883 .
Yang XO , Yang GW , Liu ZX , et al . Resveratrol ameliorates 6-OHDA-induced neurodegeneration in Parkinson's disease mice via PI3K/Akt/GSK-3β pathway [J]. Chin J Integr Med Cardio-Cerebrovasc Dis , 2020 , 18 ( 12 ): 1880 - 1883 .
Han R , Yu Y , Zhao K , et al . Lignans from eucommia ulmoides oliver leaves exhibit neuroprotective effects via activation of the PI3K/Akt/GSK-3β/Nrf2 signaling pathways in H(2)O(2)-treated PC-12 cells [J]. Phytomedicine , 2022 , 101 : 154124 .
Fahmy MI , Elrayess RA , Althobaiti MM , et al . Chicoric acid alleviates rotenone-induced motor dysfunction in mice: targeting PI3K/AKT/caspase-3-associated apoptosis and neuroinflammation [J]. Arch Pharm (Weinheim) , 2025 , 358 ( 3 ): e2400935 .
Sharma N , Soni R , Sharma M , et al . Chlorogenic acid: a polyphenol from coffee rendered neuroprotection against rotenone-induced Parkinson's disease by GLP-1 secretion [J]. Mol Neurobiol , 2022 , 59 ( 11 ): 6834 - 6856 .
Wang T , Li C , Han B , et al . Neuroprotective effects of danshensu on rotenone-induced Parkinson's disease models in vitro and in vivo [J]. BMC Complement Med Ther , 2020 , 20 ( 1 ): 20 .
Wu H , Ni C , Zhang Y , et al . Stem-leaf saponins of panax notoginseng attenuate experimental Parkinson's disease progression in mice by inhibiting microglia-mediated neuroinflammation via P2Y2R/PI3K/AKT/NFκB signaling pathway [J]. Chin J Nat Med , 2025 , 23 ( 1 ): 43 - 53 .
Yu X , Fang Y , Zhang J , et al . Glycyrrhizic acid combined with human adipose-derived MSCs synergistically alleviates the MPP+/MPTP-induced Parkinson's disease by inducing autophagy through PI3K/AKT/HIF-1α pathway [J]. Stem Cell Res Ther , 2025 , 16 ( 1 ): 500 .
Liu L , Li Z , Qin X , et al . Astragaloside Ⅳ improves neuroinflammation in Parkinson's disease by regulating amino acid metabolism and the PI3K-AKT signaling pathway [J]. Neuropharmacology , 2025 , 280 : 110661 .
Zhang TQ , Li CC , Zhang T F , et al . Mechanism of astragaloside Ⅳ alleviating PC12 cell injury by activating PI3K/AKT signaling pathway: based on network pharmacology and in vitro experiments [J]. China J Chin Mater Med , 2021 , 46 ( 24 ): 6465 - 6473 .
Feng Z , Jin C , Zhang Y , et al . Tandem mass tags quantitative proteomics reveal the mechanism by which paeoniflorin regulates the PI3K/AKT and BDNF/CREB signaling pathways to inhibit Parkinson's disease [J]. Int J Mol Sci , 2025 , 26 ( 13 ): 6498 .
Chen CH , Hsu PC , Hsu SW , et al . Protective effects of jujubosides on 6-OHDA-induced neurotoxicity in SH-SY5Y and SK-N-SH cells [J]. Molecules , 2022 , 27 ( 13 ): 4106 .
Qiao J , Zhao Y , Liu Y , et al . Neuroprotective effect of ginsenoside Re against neurotoxin‑induced Parkinson's disease models via induction of Nrf2 [J]. Mol Med Rep , 2022 , 25 ( 6 ): 215 .
谢元 , 胡烨烨 , 李甫 , 等 . 基于PI3K/Akt信号通路研究积雪草中微量皂苷(CA-1)的神经保护作用 [J]. 现代食品科技 , 2022 , 38 ( 10 ): 62 - 70 .
Xie Y , Hu YY , Li F , et al . Neuroprotective effects of a minor saponin from centella asiatica (CA-1)based on PI3K/Akt signaling pathway [J]. Mod. Food Sci. Technol , 2022 , 38 ( 10 ): 62 - 70 .
Wang H , Wu S , Jiang X , et al . Acteoside alleviates salsolinol-induced Parkinson's disease by inhibiting ferroptosis via activating Nrf2/SLC7A11/GPX4 pathway [J]. Exp Neurol , 2025 , 385 : 115084 .
Wang SY , Li MM , Wang L , et al . Schisandra chinensis (turcz.) baill neutral polysaccharides alleviate Parkinson's disease via effectively activating MCL-1 expression regulation of autophagy signaling [J]. Int J Biol Macromol , 2024 , 279 ( Pt 1 ): 134952 .
李鹏 , 杜园园 , 文杰 , 等 . 枸杞多糖通过激活PI3K/Akt通路调节MPP+诱导的帕金森病模型细胞凋亡 [J]. 中国药物与临床 , 2020 , 20 ( 01 ): 28 - 30 .
Li P , Du YY , Wen J , et al . Lycium barbarum polysaccharide regulates MPP⁺-induced apoptosis in Parkinson's disease model cells by activating PI3K/Akt pathway [J]. Chin Remedies & Clin , 2020 , 20 ( 1 ): 28 - 30 .
Tan Y , Yin L , Sun Z , et al . Astragalus polysaccharide exerts anti-Parkinson via activating the PI3K/AKT/mTOR pathway to increase cellular autophagy level in vitro [J]. Int J Biol Macromol , 2020 , 153 : 349 - 356 .
Wang Z , Huang PE , Wang N , et al . β-asarone inhibits autophagy by activating the PI3K/Akt/mTOR pathway in a rat model of depression in Parkinson's disease [J]. Behav Brain Res , 2024 , 465 : 114966 .
Wang L , Tian S , Ruan S , et al . Neuroprotective effects of cordycepin on MPTP-induced Parkinson's disease mice via suppressing PI3K/AKT/mTOR and MAPK-mediated neuroinflammation [J]. Free Radic Biol Med , 2024 , 216 : 60 - 77 .
Anandan A , Ak MU , Saika S , et al . Shikonin ameliorates rotenone-induced neurotoxicity through inhibition of apoptosis via IGF-1R/PI3K/AKT pathway in a Parkinson's disease-associated SH-SY5Y cell model [J]. Mol Neurobiol , 2025 , 62 ( 7 ): 8912 - 8930 .
Wang K , Zhang B , Tian T , et al . Taurine protects dopaminergic neurons in paraquat-induced Parkinson's disease mouse model through PI3K/Akt signaling pathways [J]. Amino Acids , 2022 , 54 ( 1 ): 1 - 11 .
Zhang X , Wang R , Finiuk N , et al . Active compounds from calendula officinalis flowers act via PI3K and ERK signaling pathways to offer neuroprotective effects against Parkinson's disease [J]. Food Sci Nutr , 2024 , 12 ( 1 ): 450 - 458 .
Wu LK , Agarwal S , Kuo CH , et al . Artemisia leaf extract protects against neuron toxicity by TRPML1 activation and promoting autophagy/mitophagy clearance in both in vitro and in vivo models of MPP+/MPTP-induced Parkinson's disease [J]. Phytomedicine , 2022 , 104 : 154250 .
王业豪 , 王宇 , 杨津津 , 等 . 刺五加提取物调控大脑皮质代谢组学及PI3K-RAC1通路改善帕金森病的作用机制 [J]. 中药药理与临床 , 2025 , 41 ( 11 ): 78 - 83 .
Wang YH , Wang Y , Yang JJ , et al . Mechanism of ciwujia extract in improving PD by regulating cerebral cortex metabolomics and PI3K-RAC1 pathway [J]. Pharmacol Clin Chin Mater Med , 2025 , 41 ( 11 ): 78 - 83 .
胡梦妮 , 张小蕾 , 荣臻 , 等 . 基于PI3K/AKT信号通路探究天麻钩藤饮对MPTP诱导帕金森病小鼠的作用机制 [J]. 中国老年学杂志 , 2025 , 45 ( 2 ): 345 - 351 .
Hu MN , Zhang XL , Rong Z , et al . The mechanism of tianmagouteng drink on MPTP induced Parkinson's disease in mice based on PI3K/AKT signaling pathway [J]. Chin J Gerontol , 2025 , 45 ( 2 ): 345 - 351 .
Pan Y , Chen M , Pan L , et al . Shisandra decoction alleviates Parkinson's disease symptoms in a mouse model through PI3K/AKT/mTOR signalling pathway [J]. Neuropsychiatr Dis Treat , 2024 , 20 : 2011 - 2027 .
赵贝贝 , 崔晓峰 , 金远林 , 等 . 芍药甘草汤通过调控PI3K/Akt/mTOR通路对帕金森病大鼠多巴胺能神经元自噬的影响 [J]. 中成药 , 2023 , 45 ( 9 ): 3058 - 3062 .
Zhao BB , Cui XF , Jin YL , et al . Effect of shaoyao gancao decoction on autophagy of dopaminergic neurons in Parkinson's disease rats by regulating PI3K/Akt/mTOR pathway [J]. Chin Trad Pat Med , 2023 , 45 ( 9 ): 3058 - 3062 .
Jiang Y , Wu W , Xie L , et al . Molecular targets and mechanisms of sijunzi decoction in the treatment of Parkinson's disease: evidence from network pharmacology, molecular docking, molecular dynamics simulation, and experimental validation [J]. Front Pharmacol , 2024 , 15 : 1487474 .
张之菁 , 梁建庆 . 基于PI3K/AKT/mTOR信号通路探讨复方地黄颗粒对帕金森病阴虚动风证大鼠的影响 [J]. 中国中医药信息杂志 , 2024 , 31 ( 7 ): 83 - 90 .
Zhang ZJ , Liang JQ . Exploration on the effects of compound dihuang granules on Parkinson disease rats with yin deficiency and wind movement syndrome based on PI3K/AKT/mTOR signaling pathway [J]. Chin J Inf Tradit Chin Med , 2024 , 31 ( 7 ): 83 - 90 .
Hang W , Fan HJ , Li YR , et al . Wuzi yanzong pill attenuates MPTP-induced Parkinson's disease via PI3K/Akt signaling pathway [J]. Metab Brain Dis , 2022 , 37 ( 5 ): 1435 - 1450 .
高崇 , 李志 . 熄风定颤汤联合多潘立酮对帕金森患者认知功能、神经递质水平的影响 [J]. 辽宁医学杂志 , 2024 , 38 ( 1 ): 73 - 76 .
Gao C , Li Z . Effects of xifeng dingzhan decoction combined with domperidone on cognitive function and neurotransmitter levels in patients with Parkinson's disease [J]. Med J Liaoning , 2024 , 38 ( 1 ): 73 - 76 .
唐颖 , 梁健芬 , 张兴博 , 等 . 加味五虎追风散联合康复疗法治疗僵直少动型帕金森病的临床观察 [J]. 时珍国医国药 , 2024 , 35 ( 3 ): 673 - 675 .
Tang Y , Liang JF , Zhang XB , et al . Clinical observation of modified wuhu zhuifeng decoction combined with rehabilitation therapy in the treatment of akinetic-rigid Parkinson's disease [J]. J Li-shizhen Tradit Chin Med , 2024 , 35 ( 3 ): 673 - 675 .
0
浏览量
110
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621
